TAC Q1 2026 Earnings EPS Misses Estimates as Operational Headwinds Persist IZEA Q4 2025 Earnings EPS Misses Estimates Stock Rises in AfterHours Trading GRRR Q4 2025 Earnings Significant EPS Miss but Stock Rises Over 12 WKHS Q1 2026 Earnings Deepening Losses Amid Operational Transition Capricor Therapeutics Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues to Invest in RD SOHOO Q2 2025 Earnings Preferred Dividend Coverage Maintained Amid Stable Operations